[1]
L. Balasundaram, J. Mathaiyan, S. B. S., and S. K. Kamalanathan, “Influence of SLC22A1 gene polymorphisms on gastrointestinal adverse effects with metformin therapy in South Indian type 2 diabetes mellitus patients”, Int J Basic Clin Pharmacol, vol. 13, no. 2, pp. 261–267, Feb. 2024.